NEW YORK, December 15, 2015—Kantar Health, a leading global healthcare consulting and market research firm, has acquired CEEOR, strengthening Kantar Health’s commercial effectiveness business and more powerfully positioning it as a leader of sales force productivity and promotional effectiveness solutions. The acquisition also expands Kantar Health’s real-world research and value practice into Central Europe.
Based in Prague and with offices in Slovakia and Hungary, CEEOR is a research and consulting firm that operates throughout the whole of Europe and specializes in delivering real-time competitive intelligence data, analytical solutions, and advisory and implementation services to the pharmaceutical, biotechnology and healthcare industries across Europe. Its technology platform provides continuous, real-time monitoring of sales and marketing activities of pharmaceutical products.
“Acquiring CEEOR adds to Kantar Health’s already strong suite of commercial effectiveness solutions, enabling us to continue to drive business results for our clients by helping them develop go-to-market strategies and optimize sales, marketing and brand performance,” said Michel Murino, European CEO, Kantar Health. “The acquisition brings together two highly talented teams in Kantar Health and CEEOR, with deep research and consulting experience, and further strengthens Kantar Health’s presence within Europe’s healthcare market.”
Through this acquisition, clients will gain further access to industry-leading data and real-world insights essential to evaluating their commercial effectiveness.
“CEEOR has proven to be a valuable and flexible partner to our pharma and healthcare industry clients in Europe,” said Aleš Tichopad, Founder and Director, CEEOR. “We are excited to become part of Kantar Health and to offer our clients more international competencies that complement the local services they value. We look forward to continuing to build on our personal client relationships and delivering our top-of-the-line commercial effectiveness offer.”
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.
CEEOR was founded in 2006 as a research and consulting firm specializing in analytical services to pharmaceutical, biotechnology and healthcare industries in Europe and beyond. The company is headquartered in Prague, Czech Republic, with offices in Slovakia and Hungary. CEEOR specializes in delivering real-time competitive intelligence data, analytical solutions, and advisory and implementation services to the pharmaceutical, biotechnology and healthcare industries in Europe. The company is focused on delivering commercial effectiveness, late-phase research, market research and technology solutions to clients. Its technology platform provides continuous and real-time monitoring of sales and marketing activities of pharmaceutical products.